Current Drug Abuse Reviews
Title: Editorial (The 2D:4D Digit Ratio: A Biomarker of Alcohol and Drug Abuse?)
Volume: 4 Issue: 2
Author(s): Joris C. Verster and Lydia de Haan
Affiliation:
Export Options
About this article
Cite this article as:
C. Verster Joris and de Haan Lydia, Editorial (The 2D:4D Digit Ratio: A Biomarker of Alcohol and Drug Abuse?), Current Drug Abuse Reviews 2011; 4 (2) . https://dx.doi.org/10.2174/1874473711104020065
DOI https://dx.doi.org/10.2174/1874473711104020065 |
Print ISSN 1874-4737 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4745 |
25
Related Articles
-
Study of Atomic Force Microscopy in Pharmaceutical and Biopharmaceutical Interactions - A Mini Review
Current Pharmaceutical Analysis Hepatic Effects of Duloxetine – III: Analysis of Hepatic Events Using External Data Sources
Current Drug Safety Modulation of Eating by Central Catecholamine Systems
Current Drug Targets Prostaglandin EP Receptor Subtypes Involved in Regulating HCO3- Secretion from Gastroduodenal Mucosa
Current Pharmaceutical Design Gender Differences in the Clinical Presentation of Heart Disease
Current Pharmaceutical Design Pharmacologic Therapy in Growth Hormone Disorders and the Heart
Current Medicinal Chemistry Preface [Hot Topic: Current Trends in the Development of Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents (Executive Editors: P. Camps and D. Munoz-Torrero)]
Current Pharmaceutical Design ET-18-OCH3 (Edelfosine): A Selective Antitumour Lipid Targeting Apoptosis Through Intracellular Activation of Fas / CD95 Death Receptor
Current Medicinal Chemistry Neural Induction of Adult Bone Marrow and Umbilical Cord Stem Cells
Current Neurovascular Research Systemic and CNS Inflammation Crosstalk: Implications for Alzheimer’s Disease
Current Alzheimer Research Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
Drug Metabolism Letters Editorial [Hot Topic: Therapeutic Application of Melanocortin-4 Receptor Ligands (Guest Editor: John P. Mayer)]
Current Topics in Medicinal Chemistry Predicting Dopamine Receptors Binding Affinity of N-[4-(4-Arylpiperazin- 1-yl) butyl]Aryl Carboxamides: Computational Approach Using Topological Descriptors
Current Drug Discovery Technologies Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders
Central Nervous System Agents in Medicinal Chemistry Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin
Current Pharmaceutical Design Assay of Biogenic Monoamines in Milk by Fluorescence-LC Following Derivatization with Naphthalene-2,3-dicarboxaldehyde
Current Analytical Chemistry Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition
Current Neuropharmacology Development of BACE1 Inhibitors for Alzheimers Disease
Current Medicinal Chemistry Synthesis and Biological Evaluation of Novel Thiazol-2yl-amine Derivatives as Potential Anticancer Agents
Letters in Organic Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery